Biobeat Technologies developed the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system that is a patch-worn, cuff-less solution for diagnosis and treatment of hypertension. Biobeat expands the use of ABPM for hypertensive patients and providing 24-hour blood pressure data. Its system enables comfort and uninterrupted sleep for patients while capturing critical nighttime BP measurements.
Read More:Biobeat raises a $50M Series B for its US expansion – Refresh Miami
Posted in